|
Quotes & Info
|
| HNAB.OB > SEC Filings for HNAB.OB > Form 8-K on 5-Nov-2009 | All Recent SEC Filings |
5-Nov-2009
Change in Directors or Principal Officers
On October 30, 2009, John P. Iparraguirre submitted his resignation as Vice President, Chief Financial Officer and Secretary of Hana Biosciences, Inc. (the "Company"), effective as of November 16, 2009.
On November 5, 2009, Tyler M. Nielsen, currently the Company's controller and principal accounting officer, was appointed interim Chief Financial Officer of the Company, effective upon the effective date of Mr. Iparraguirre's resignation. Mr. Nielsen, age 31, has been the Company's controller since February 2006. From September 2003 to February 2006, Mr. Nielsen was a senior auditor at Ernst & Young LLP. There are no family relationships between Mr. Nielsen and any other officer or director of the Company. Mr. Nielsen will continue to receive his annualized base salary of $140,000 and will be eligible to receive an annual bonus to be determined in the sole discretion of the Company's Board of Directors.
|
|